SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-16-132227
Filing Date
2016-11-08
Accepted
2016-11-07 21:18:28
Documents
18
Group Members
MAYNE PHARMA GROUP LTDMAYNE PHARMA INTERNATIONAL PTY LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v452300_sc13da.htm SC 13D/A 83329
2 EXHIBIT 99.1 v452300_ex99-1.htm EX-99.1 4106
3 EXHIBIT 99.5 v452300_ex99-5.htm EX-99.5 9486
4 GRAPHIC ex99-5_001.jpg GRAPHIC 532485
5 GRAPHIC ex99-5_002.jpg GRAPHIC 714616
6 GRAPHIC ex99-5_003.jpg GRAPHIC 661223
7 GRAPHIC ex99-5_004.jpg GRAPHIC 205033
8 GRAPHIC ex99-5_005.jpg GRAPHIC 205640
9 GRAPHIC ex99-5_006.jpg GRAPHIC 236939
10 GRAPHIC ex99-5_007.jpg GRAPHIC 249219
11 GRAPHIC ex99-5_008.jpg GRAPHIC 201287
12 GRAPHIC ex99-5_009.jpg GRAPHIC 692590
13 GRAPHIC ex99-5_010.jpg GRAPHIC 184844
14 GRAPHIC ex99-5_011.jpg GRAPHIC 193190
15 GRAPHIC ex99-5_012.jpg GRAPHIC 161391
16 GRAPHIC ex99-5_013.jpg GRAPHIC 34757
17 GRAPHIC ex99-5_014.jpg GRAPHIC 90854
18 GRAPHIC ex99-5_015.jpg GRAPHIC 44442
  Complete submission text file 0001144204-16-132227.txt   6172557
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Subject) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51823 | Film No.: 161979818
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address LEVEL 1, 99 KING STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 1, 99 KING STREET MELBOURNE, VICTORIA C3 3000 011-61-3-8614-7777
Mayne Pharma Ventures Pty Ltd (Filed by) CIK: 0001611535 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: SC 13D/A